What is Naveen Lobo's NPI number?

Naveen Lobo's National Provider Identifier (NPI) is 1023025434, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Naveen Lobo's specialty?

Naveen Lobo is listed in the NPPES registry with a primary specialty of Medical Oncology Physician (Allopathic & Osteopathic Physicians).

Where is Naveen Lobo located?

Naveen Lobo's practice location on file with NPPES is 1310 14th Ave Se, Decatur, AL 35601-4347.

What is Naveen Lobo's phone number?

The practice phone number listed in the NPPES registry for Naveen Lobo is (256) 705-4224.

Does Naveen Lobo accept Medicare?

Naveen Lobo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Naveen Lobo's NPI active?

Yes — Naveen Lobo's NPI (1023025434) is active in the NPPES registry as of the last update on 2023-01-27.

IndividualActiveAccepts Medicare

Naveen Lobo, MD

NPI 1023025434 · Medical Oncology Physician · Decatur, AL

Naveen Lobo, MD is a Medical Oncology Physician provider in Decatur, AL (NPI 1023025434).

Provider details

NPI number: 1023025434
Entity type: Individual
Primary specialty: Medical Oncology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: 25921 (AL)

Practice location

1310 14th Ave Se

Decatur, AL 35601-4347

Phone: (256) 705-4224

Street-level locationGet directions

More AL providers

Mailing address

Po Box 18428

Huntsville, AL 35804-8428

Specialties & taxonomies

Medical Oncology PhysicianPrimary207RX0202XLicense 25921 (AL)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
24,371 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025	3,077	$8
Insertion of Needle Into Vein for Collection of Blood Sample36415	2,942	$9
Blood Test, Comprehensive Group of Blood Chemicals80053	2,599	$10
Injection of Additional New Drug Or Substance Into Vein96375	1,289	$13
Injection of Drug Or Substance Under Skin Or Into Muscle96372	1,189	$13
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,113

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 44 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Anastrozole	102	36
Apixabanbrand: Eliquis	92	25
Rivaroxabanbrand: Xarelto	83	20
Metoclopramide Hcl	71	48
Ibrutinibbrand: Imbruvica	70	—
Imatinib Mesylate	67	—
Ondansetronbrand: Ondansetron Odt	65

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,005 across 43 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-08-01
Last updated: 2023-01-27
Certified: 2023-01-27

Frequently asked questions

What is Naveen Lobo's NPI number?: Naveen Lobo's National Provider Identifier (NPI) is 1023025434, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Naveen Lobo's specialty?: Naveen Lobo is listed in the NPPES registry with a primary specialty of Medical Oncology Physician (Allopathic & Osteopathic Physicians).
Where is Naveen Lobo located?: Naveen Lobo's practice location on file with NPPES is 1310 14th Ave Se, Decatur, AL 35601-4347.
What is Naveen Lobo's phone number?: The practice phone number listed in the NPPES registry for Naveen Lobo is (256) 705-4224.
Does Naveen Lobo accept Medicare?: Naveen Lobo is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Naveen Lobo's NPI active?: Yes — Naveen Lobo's NPI (1023025434) is active in the NPPES registry as of the last update on 2023-01-27.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025	3,077	$8
Insertion of Needle Into Vein for Collection of Blood Sample36415	2,942	$9
Blood Test, Comprehensive Group of Blood Chemicals80053	2,599	$10
Injection of Additional New Drug Or Substance Into Vein96375	1,289	$13
Injection of Drug Or Substance Under Skin Or Into Muscle96372	1,189	$13
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,113

Drug

Part D claims (2024)

Beneficiaries

Anastrozole

102

Apixabanbrand: Eliquis

Rivaroxabanbrand: Xarelto

Metoclopramide Hcl

Ibrutinibbrand: Imbruvica

—

Imatinib Mesylate

—

Ondansetronbrand: Ondansetron Odt

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,005 across 43 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments